Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response

Vaccine

Volumn 16, Issue 2-3, 1998, Pages 313-319

  Nieminen, Tea ^a   Käyhty, Helena ^a   Virolainen, Anni ^a   Eskola, Juhani ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antibody secreting cells; Mucosal response; Pneumococcal vaccines

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; PRIORITY JOURNAL; SALIVA; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIAL VACCINES; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; SALIVA; STREPTOCOCCUS PNEUMONIAE;

EID: 0031986205     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00162-X     Document Type: Article

References (33)

1. 1 Gowans, J.L. and Knight, E.J. The route of re-circulation of lymphocytes in the rat. Proc. Roy. Soc. (Ser B) 1964, 159, 257.
2. 2 Strober, W. and Jacobs, D. Cellular differentiation, migration and function in the mucosal immune system. In Advances in Host Mucosal Defence Mechanisms (Eds Gallin, J.I. and Fauci, A.S.), 1985, Vol. 4, pp. 1-30.
3. 3 McDermot, M.R. and Bienenstock, J. Evidence for a common mucosal immune system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. J. Immunol. 1979, 122, 1892.
4. 4 Kilian, M. Degradation of immunoglobulin A1, A2 and G by suspected principal periodontal pathogens. Infect. Immunol. 1981, 34, 757.
5. 5 Kilian, M. and Holmgren, K. Ecology and nature of immunoglobulin A1 protease-producing streptococci in the human oral cavity and pharynx. Infect. Immunol. 1981, 31, 868.
6. 6 Austrian, R., Douglas, R.M. and Schiffman, G. et al. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Physicians 1976, 89, 184.
7. 7 Heilmann, C. and Pedersen, F.K. Quantitation of blood lymphocytes secreting antibodies to pneumococcal polysaccharides after in vivo antigenic stimulation. Scand. J. Immunol. 1986, 23, 189.
8. 8 Heilman, C., Barington, T. and Sigsgaard, T. Subclass of individual IgA human lymphocytes. Investigation of In Vivo pneumococcal polysaccharide-induced and in vitro mitogen-induced blood B cells by monolayer plaque-forming cell assays. J. Immunol. 1988, 140, 1496.
9. 9 Lue, C., Tarkowski, A. and Mestecky, J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J. Immunol. 1988, 140, 3793.
10. 10 Lue, C., Prince, S.J., Fattom, A., Schneerson, R., Robbins, J.B. and Mestecky, J. Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12 F polysaccharide and diphteria toxoid. Infect. Immunol. 1990, 57, 2547.
11. 11 Mäkelä, P.H., Karma, P., Sipilä, M., Pukander, J. and Leinonen, M. Possibilities of preventing otitis media by vaccination. Scand. J. Infect. Dis. 1983, 39, (Suppl.), 34.
12. 12 Leinonen, M., Säkkinen, A., Kalliokoski, R., Luotonen, J., Timonen, M. and Mäkelä, P.H. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr. Infect. Dis. 1986, 5, 39.
13. 13 Anderson, E.L., Kennedy, D.J., Geldmacher, K.M., Donnelly, J. and Mendelman, P.M. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J. Pediatrics 1996, 128, 649.
14. 14 Käyhty, H., Åhman, Rönnberg, P.R., Tillikainen, R. and Eskola, J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J. Infect. Dis. 1995, 172, 1273.
15. 15 Takala, A.K., Eskola, J. and Leinonen, M. et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J. Infect. Dis. 1991, 164, 982.
16. 16 Murphy, T.V., Pasor, P., Medley, F., Osterholm, T. and Granoff, D.M. Decreased haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatrics 1993, 122, 517.
17. 17 Mohle-Boetani, J.C., Ajello, G. and Breneman, E. et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae. Pediatr. Infect. Dis. J. 1993, 12, 589.
18. 18 Dagan, R., Melamed, R. and Muallem, M. et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavatent conjugate pneumococcal vaccine. J. Infect. Dis. 1996, 174, 1271.
19. 19 Balows, A., Hausler, W.J. Jr, Herrmann, K.L., Isenberg, H.D. and Shadomy, H.J. (eds), Manual of Clinical Microbiology, 5th edn. American Society for Microbiology, Washington DC, 1991.
20. 20 Leinonen, M.K. Detection of pneumococcal capsular polysaccharide antigens by latex agglutination, counterimmunoelectrophoresis, and radioimmunoassay in middle ear exudates in acute otitis media. J. Clin. Microbiol. 1980, 11, 135.
21. 21 Robbins, J.B., Lee, C.-J., Rastogi, S.C., Schiffman, G. and Henrichsen, J. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and 6B(26) capsular polysaccharides. Infect. Immunol. 1979, 26, 1116.
22. 22 Robbins, J.B., Austrian, R. and Lee, C.-J. et al. Consideration for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J. Infect. Dis. 1983, 148, 1136.
23. 23 Nieminen, T., Virolainen, A. and Käyhty, H. et al. Antibody secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media. J. Infect Dis. 1996, 173, 136.
24. 24 Quataert, S.A., Kirch, C.S. and Wiedl, L.J. et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, Lot 89-S. Clin. Diagn. Lab. Immunol. 1995, 2, 590.
25. 25 Virolainen, A., Jero, J., Käyhty, H., Karma, P., Leinonen, M. and Eskola, J. Nasopharyngeal antibodies to pneumococcal capsular polysaccharides in children with acute otitis media. J. Infect. Dis. 1995, 172, 1115.
26. 26 Mäkelä, P.H. and Karma, P. Vaccination trials in otitis media: experiences in Finland since 1977. J. Pediatr. Infect. Dis. 1989, 8S, 79.
27. 27 Powers, D.C., Anderson, E.L., Lottenbach, K. and Mink, C.M. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J. Infect. Dis. 1996, 173, 1014.
28. 28 Eby, R. Pneumococcal conjugate vaccines. In: Vaccine Design: The Subunit and Adjuvant Approach. Plenum Press, New York, 1995, Chap. 31, pp. 695-718.
29. 29 Fattom, A., Lue, C. and Szu, S. et al. Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphteria toxoid. Infect. Immunol. 1990, 58, 2309.
30. 2-subclass antibody responses. J. Immunol. 1990, 144, 3770.
31. 31 Granoff, D.M. and Lucas, A.M. Laboratory correlates of protection against haemophilus influenzae type b disease. Importance of assessmentment of antibody avidity and immunological memory. Ann. N.Y. Acad. Sci. 1995, 745, 278.
32. 32 Butcher, E.C. and Picker, L.J. Lymphocyte homing and Homeostasis. Science 1996, 272, 60.
33. 33 Abitorabi, M.A., Mackay, C.R., Jerome, E.H., Osorio, O., Butcher, E.C. and Erie, D.J. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral and lung lymph. J. Immunol. 1996, 156, 3111.